FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine, biology, nanothechnology, and deals with obtaining immunogenic compositions. Claimed immunogenic composition contains 1) platform-carrier, for which used are spherical particles, obtained by thermal structural restructuring of viruses belonging to group of tobacco mosaic virus (tobamoviruses) or other plant viruses with spiral structure and 2) foreign proteins/antigens/epitopes, bound with surface of spherical particles. Foreign antigen/epitope in composition of complex with spherical particles demonstrates high immunogenicity and preserves antigenic specificity.
EFFECT: claimed compositions are biologically safe, stable.
10 ex, 13 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| THE METHOD OF IMMUNE RESPONSE ENHANCEMENT | 2010 |
|
RU2442604C1 |
| NEW TYPE OF CARRIER PARTICLES (PLATFORMS) FOR PRODUCTION OF ACTIVE COMPLEXES | 2010 |
|
RU2441667C1 |
| RUBELLA VACCINE ON THE BASIS OF A STRUCTURALLY-MODIFIED VIRUS OF PLANTS AND A METHOD FOR ITS PRODUCTION | 2016 |
|
RU2660563C2 |
| VIRIONS AND VIRUS-LIKE PARTICLES OF ALTERNANTHERA MOSAIC VIRUS AS AMPLIFIERS OF IMMUNE RESPONSE | 2015 |
|
RU2639491C2 |
| PLANT VIRUS RECOMBINANT ANTHRAX VACCINE | 2023 |
|
RU2821917C1 |
| ANTIGEN FOR RECOMBINANT VACCINE AGAINST RUBELLA VIRUS | 2019 |
|
RU2709328C1 |
| VACCINE PREPARATION | 2009 |
|
RU2409386C1 |
| METHOD OF PREPARING BIOLOGICALLY ACTIVE COMPLEX | 2009 |
|
RU2427386C1 |
| METHOD OF PRODUCING PREPARATIVE QUANTITIES OF PHLOEM-RESTRICTED VIRAL ANTIGENS | 2012 |
|
RU2525136C1 |
| UNIVERSAL AVIAN INFLUENZA VIRUS VACCINE | 2007 |
|
RU2358981C2 |
